Mitani, S., & Muro, K. (2017). No benefit from ramucirumab in first-line chemotherapy? Transl Gastroenterol Hepatol.
Style de citation ChicagoMitani, Seiichiro, et Kei Muro. "No Benefit From Ramucirumab in First-line Chemotherapy?" Transl Gastroenterol Hepatol 2017.
Style de citation MLAMitani, Seiichiro, et Kei Muro. "No Benefit From Ramucirumab in First-line Chemotherapy?" Transl Gastroenterol Hepatol 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.